학술논문

Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Final Results of CheckMate 722
Document Type
Article
Source
In: Journal of Clinical Oncology. (Journal of Clinical Oncology, 10 April 2024, 42(11):1252-1264)
Subject
Language
English
ISSN
15277755
0732183X